Analysts review Sutro Biopharma Inc’s rating

Jaxson Clark

Sutro Biopharma Inc’s recently made public that its CHIEF SCIENTIFIC OFFICER Gerber Hans-Peter acquired Company’s shares for reported $13607.0 on Oct 15 ’25. In the deal valued at $0.80 per share,17,000 shares were bought. As a result of this transaction, Gerber Hans-Peter now holds 71,832 shares worth roughly $83325.12.

Then, Chow Gregory K. bought 19,750 shares, generating $15,998 in total proceeds. Upon buying the shares at $0.81, the CFO now owns 19,750 shares.

Before that, Chung Jane bought 12,500 shares. Sutro Biopharma Inc shares valued at $10,011 were divested by the Chief Executive Officer at a price of $0.80 per share. As a result of the transaction, Chung Jane now holds 122,850 shares, worth roughly $0.14 million.

Piper Sandler upgraded its Sutro Biopharma Inc [STRO] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who decreased its forecast for the stock in mid March from “a Buy” to “a Neutral”. Wedbush also remained covering STRO and has decreased its forecast on March 14, 2025 with a “Neutral” recommendation from previously “an Outperform” rating. Citizens JMP revised its rating on March 14, 2025. It rated STRO as “a Mkt perform” which previously was an “a Mkt outperform”.

Price Performance Review of STRO

On Monday, Sutro Biopharma Inc [NASDAQ:STRO] saw its stock jump 10.48% to $1.16. Over the last five days, the stock has gained 1.75%. Sutro Biopharma Inc shares have fallen nearly -66.86% since the year began. Nevertheless, the stocks have fallen -36.96% over the past one year. While a 52-week high of $4.60 was reached on 01/24/25, a 52-week low of $0.52 was recorded on 04/17/25.

Levels Of Support And Resistance For STRO Stock

The 24-hour chart illustrates a support level at 1.0617, which if violated will result in even more drops to 0.9633. On the upside, there is a resistance level at 1.2167. A further resistance level may holdings at 1.2733.

How much short interest is there in Sutro Biopharma Inc?

A steep rise in short interest was recorded in Sutro Biopharma Inc stocks on 2025-10-15, dropping by 11233.0 shares to a total of 2.51 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 2.52 million shares. There was a decline of -0.45%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.